K

KBI Biopharma

CDMO delivering cell line development

Quality Assurance Specialist 2

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeDurham, NC, USANo salary listed

About the Job

Requirements

  • BS and 11+ years experience or MS and 8+ years experience in a CGMP regulated environment within biopharmaceuticals or equivalent
  • Experience in QA review of analytical data (release, in-process, and stability), experience in reviewing method qualifications/validations and the review and approval of laboratory investigations and deviations. Knowledge of USP, EU and JP cGMP guidelines.
  • Ability to read, analyze, and interpret general business periodicals, professional journals, technical procedures, or governmental regulations.
  • Ability to write reports, business correspondence, and procedure manuals. Ability to effectively present information and respond to questions from groups of managers, clients, customers, and the general public.
  • Ability to solve practical problems and deal with a variety of concrete variables in situations where only limited standardization exists.
  • Ability to interpret a variety of instructions furnished in written, oral, diagram, or schedule form.
  • Basic math skills are required.
  • Ability to apply concepts of basic algebra and statistics.
  • Be able to sit for long periods of time.
  • Ability to lift 20 pounds.
  • Ability to use word processing, database, spreadsheets, power point, internet, e-mail, calendar, computer, telephone

Responsibilities

  • Performs compliance review on the following records: release, in-process, and stability data.
  • Responsible for the review and approval of method qualifications and validations
  • Responsible for the review and approval of deviations and laboratory investigations.
  • Desirable": None

About the Company

KBI Biopharma

CDMO delivering cell line development

KBI Biopharma is a CDMO that accelerates the development of biological medicines by providing rapid cell line generation and process development for preclinical programs. It uses established mammalian and microbial expression systems (such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli) to create production cell lines and develop integrated manufacturing processes. Compared with competitors, it wins on speed, end-to-end capability, and flexibility across multiple platforms to move projects quickly from discovery to preclinical milestones for a diverse client base. Its goal is to reduce risk, shorten development timelines, and expand global access to life-saving biologic therapies.

Company size
1,001-5,000
Company stage
Late Stage VC
Total funding
$109.5M
Headquarters
Durham, NC
Founded
1996

Recently Posted Jobs

Explore more opportunities at KBI Biopharma

See more jobs